Charleston, SC -- (SBWIRE) -- 10/22/2013 -- otcstockcenter.com, provide information specifically for trades in the micro cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Lets have a look on Few Hot Stocks, NanoTech Entertainment, Inc.(OTCMKTS:NTEK), Pan Global Corp(OTCMKTS:PGLO), Societe Generale SA (ADR)(OTCMKTS:SCGLY), Affymax, Inc.(OTCMKTS:AFFY)
NanoTech Entertainment, Inc.(OTCMKTS:NTEK) closed latest trading day at $0.141, up +5.22%, on volume of over 4.58 million shares. The stock went up 22.61% in the last 5 days. Its average trading volume is 6.32 million shares. In the time frame of the last one month, the share-price has surged almost 35.58%. Its market capitalization was $74.49 million. NanoTech Entertainment, Inc. operates as a technology company with focus on entertainment industry worldwide.
What was the Moving Force behind NTEK On Bullish Run? Read This Research Report on NTEK
With the latest rise of +45.60%, Pan Global Corp(OTCMKTS:PGLO) now has YTD performance -81.8% which for the week is negative at -81.8%. The total number of shares traded on the latest trading day was about 4.44 million shares, and changed hands at price range of $0.30 to $0.36 apiece. The company ended previous trading at $0.25. Pan Global, Corp. operates as a renewable energy technology and sustainable infrastructure company in the United States.
For How Long PGLO will Fight for Profitability? Read This Trend Analysis report
Societe Generale SA (ADR)(OTCMKTS:SCGLY) reported the price of the stock declined -2.33% and finished the day at $11.33 on above average volume. The total number of shares traded on the latest trading day was about 326,924.00 shares, and changed hands at price range of $11.33 to $11.45 apiece. The shares rushed about 52.49% since the start of year and have at 47.49% gain in last three months. Narrowing down the performance period, the stock rose 11.3% for the month and at 1.89% gain over the week. Societe Generale Group provides retail banking, specialized financial and insurance, private banking, investment management, and corporate and investment banking services worldwide.
Why Should Investors Buy SCGLY After the Recent Fall? Just Go Here and Find Out
Affymax, Inc.(OTCMKTS:AFFY) ended previous trading at $1.15, losing -0.87%.The total number of shares traded on the latest trading day was about 444,436.00 shares. In the last 5 days it showed a drop of -5% and on its one month graph, shares are -5% down. The stock has a 52-week high price of $27.59 and its 52-week low was recorded at $0.78. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Will AFFY Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)